BACKGROUND: Zellweger spectrum disorder (ZSD) is an autosomal recessive peroxisome biogenesis disorder (PBD) caused by bi-allelic mutations in any of the 13 PEX family genes. METHODS: We reported a Chinese PBD-ZSD patient with compound heterozygous mutations of PEX6 detected by target sequencing and Sanger sequencing. The clinical materials were collected. In silico analysis were used to evaluate the pathogenicity of the two mutations. An updated review summarized the genotype-phenotype correlation of PBD patients with PEX6 mutations. RESULTS: The patient was diagnosed as PBD-ZSD and displayed retinitis pigmentosa, bilateral sensorineural hearing loss, hypotonia, developmental delay, ovarian and enamel dysplasia. Elevated very long chain fatty acids were shown and a pattern of leukodystrophy was displayed through MRI. The two mutations were novel with p.Cys358* and p.Leu83Pro, both classified as pathogenic according to American College of Medical Genetics and Genomics guideline. Phenotype-genotype correlations were shown in the reported patients with PBD-ZSD continuum. CONCLUSIONS: we reported the first Chinese PBD-ZSD patient with 2 novel mutations in PEX6. Target sequencing and VLFAC were helpful in diagnosis.
BACKGROUND: Zellweger spectrum disorder (ZSD) is an autosomal recessive peroxisome biogenesis disorder (PBD) caused by bi-allelic mutations in any of the 13 PEX family genes. METHODS: We reported a Chinese PBD-ZSD patient with compound heterozygous mutations of PEX6 detected by target sequencing and Sanger sequencing. The clinical materials were collected. In silico analysis were used to evaluate the pathogenicity of the two mutations. An updated review summarized the genotype-phenotype correlation of PBD patients with PEX6 mutations. RESULTS: The patient was diagnosed as PBD-ZSD and displayed retinitis pigmentosa, bilateral sensorineural hearing loss, hypotonia, developmental delay, ovarian and enamel dysplasia. Elevated very long chain fatty acids were shown and a pattern of leukodystrophy was displayed through MRI. The two mutations were novel with p.Cys358* and p.Leu83Pro, both classified as pathogenic according to American College of Medical Genetics and Genomics guideline. Phenotype-genotype correlations were shown in the reported patients with PBD-ZSD continuum. CONCLUSIONS: we reported the first Chinese PBD-ZSD patient with 2 novel mutations in PEX6. Target sequencing and VLFAC were helpful in diagnosis.
Authors: Merel S Ebberink; Barbara Csanyi; Wui K Chong; Simone Denis; Peter Sharp; Petra A W Mooijer; Conny J M Dekker; Claire Spooner; Lock H Ngu; Carlos De Sousa; Ronald J A Wanders; Michael J Fietz; Peter T Clayton; Hans R Waterham; Sacha Ferdinandusse Journal: J Med Genet Date: 2010-07-20 Impact factor: 6.318
Authors: C P Grou; A F Carvalho; M P Pinto; I S Alencastre; T A Rodrigues; M O Freitas; T Francisco; C Sá-Miranda; J E Azevedo Journal: Cell Mol Life Sci Date: 2009-01 Impact factor: 9.261
Authors: Z Zhang; Y Suzuki; N Shimozawa; S Fukuda; A Imamura; T Tsukamoto; T Osumi; Y Fujiki; T Orii; R J Wanders; P G Barth; H W Moser; B C Paton; G T Besley; N Kondo Journal: Hum Mutat Date: 1999 Impact factor: 4.878
Authors: A Imamura; N Shimozawa; Y Suzuki; Z Zhang; T Tsukamoto; Y Fujiki; T Orii; T Osumi; R J Wanders; N Kondo Journal: Pediatr Res Date: 2000-10 Impact factor: 3.756
Authors: Annick Raas-Rothschild; Ronald J A Wanders; Petra A W Mooijer; Jeannette Gootjes; Hans R Waterham; Alisa Gutman; Yasuyuki Suzuki; Nobuyuki Shimozawa; Naomi Kondo; Gideon Eshel; Marc Espeel; Frank Roels; Stanley H Korman Journal: Am J Hum Genet Date: 2002-02-28 Impact factor: 11.025
Authors: Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev Journal: Nat Methods Date: 2010-04 Impact factor: 28.547